COPD Highlight Notice for RfPB - Deadline 16/11/2020
We are pleased to inform you the Research for Patient Benefit (RfPB) programme is inviting proposals from eligible individuals and research teams for collaborative research projects to better understand and manage the health and social care consequences of Chronic Obstructive Pulmonary Disease (COPD).
Due to the high disease burden within the North East of England, they are particularly interested in this population and therefore applications from researchers within this area will receive priority consideration. Further details can be found in the link below.
The pre-registration deadline is 16/11/2020. If you are interested in applying please let us know as soon as possible by emailing email@example.com so that we can work with you to take this forward.
PRINCIPLE Trial calls on UK primary care to support patient recruitment
The Co-Chief Investigators of the PRINCIPLE Trial, Professor Chris Butler and Professor Richard Hobbs, write an open letter to health professionals across UK primary care calling on their support, so those who are still contracting COVID-19 are given the opportunity to join the trial.
Multiverse Lab invites researchers to take part in creative development
The NIHR Newcastle BRC is leading a new, innovative PPIE initiative called Multiverse Lab, along with local NIHR partners. Multiverse Lab will create a new ‘digital experience’ for the public who have had little/no involvement in health research and inspire them to get involved.
Learn more on the NIHR Newcastle BRC website
Ensuring ethnic diversity in COVID-19 research
People from black, Asian and minority ethnic (BAME) groups are disproportionately affected by coronavirus infection, so it’s imperative that they’re included in COVID-19 research. Professor Kamlesh Khunti and Professor Azhar Farooqi from the Centre for BME Health share some tips on how to successfully involve people from BAME backgrounds in your research.
Visit the full article on the NIHR website
Digital PRES 2020/21 Surveys Launched
From Monday 1 June the digital PRES platform, accessible at MyResearchExperience.com, will be updated with new survey questions and relaunch. All of the processes and design of the website and carrying out of a questionnaire will remain the same, however there are now added surveys to collect more accurate experiences from children taking part in research.
See the full article here
First drug to reduce mortality in hospitalised patients with respiratory complications of COVID-19 found
The NIHR-funded and supported study RECOVERY (Randomised Evaluation of COVid-19 thERapY) has today announced that the steroid dexamethasone has been identified as the first drug to improve survival rates in certain coronavirus patients.
100,000 participants enroll in urgent COVID-19 research
Over 100,000 UK participants have now enrolled in COVID-19 urgent public health research supported by the National Institute for Health Research (NIHR) - at NHS hospitals and care settings across the United Kingdom.
COVID-19 drugs trial rolled out across UK homes and communities
The national priority PRINCIPLE trial is testing whether low-risk treatment in the community can help people at higher risk of complications from COVID-19 to get better quicker, reducing the need for hospital admission.
New COVID-19 BAME Research Video + Website
Minority groups are facing the greatest risk from the coronavirus and tend to have higher mortality rates as a result of the pandemic.
The Centre for Black and Minority Ethnic (BME) Health have produced a brief video encouraging members of the BAME community to participate in COVID research.
New courses and resources on NIHR Learn
There are a number of new NIHR Learn courses and resources relevant to staff both new and already active in research. Available through the NIHR Learn platform, new items include a break down of the design of Covid-19 studies, research fundamentals for Lab staff and more.
£14.1 million funding announced for new COVID-19 research on treatments, vaccines and epidemiology
Twenty-one new studies into the novel coronavirus have been funded by the NIHR and UK Research and Innovation (UKRI).
The new research projects include the first drug trial in primary care, studies on new vaccines and therapies, and research into disease transmission, behavioral interventions and policy approaches to COVID-19.
NIHR publishes latest Annual Report
The NIHR has published its latest Annual Report highlighting its achievements in 2018/19.
The report celebrates all the NIHR support and funding that has the most impact on our health and social care system. It details our ground-breaking research, and often world-firsts, and the talents and expertise within our research community that deliver these findings.
UK’s top doctors urge recruitment of COVID-19 patients for vital scientific research
The UK’s four Chief Medical Officers and NHS England and Improvement’s’ National Medical Director have written a joint letter to every NHS Trust in the country asking that all efforts are made to enrol patients into nationally prioritised clinical trials on COVID-19.
NIHR launches new Centre for Engagement and Dissemination
The NIHR has launched a new Centre for Engagement and Dissemination that brings together its activities in patient and public involvement, engagement and participation with its strengths in research dissemination.
New application process for COVID-19 Urgent Public Health Research
The NIHR is prioritising funding and support for COVID-19 research and the NIHR Clinical Research Network (CRN) has paused site set-up for all other studies.
A single application and review process has been established for all studies, irrespective of funding source, as well as studies that require funding.
This new process will prevent duplication and ensure that the capacity of the health and care system to support research is not exceeded.
Covid-19 CRN NENC Update
During the Covid-19 pandemic, we are keeping our region's R&D and research delivery staff informed on the latest updates. We are also signposting people to the central NIHR website for further information and guidance.